Autolus Therapeutics
AUTL
$4.39
Share price
7.86%
Change (1 day)
48.81%
Change (1 year)
Categories
Autolus Therapeutics (AUTL) - Cash on Hand
Cash on Hand as of December 2023 : $0.23 B
According to Autolus Therapeutics's latest financial reports the company has $0.23 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Autolus Therapeutics - Cash on Hand chart (from 2018 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.38 B | 23.23% |
| 2021-12-31 | $0.31 B | 102.44% |
| 2020-12-31 | $0.15 B | -27.22% |
| 2019-12-31 | $0.21 B | |
| 2018-09-30 | $0.24 B | 80.19% |
| 2017-09-30 | $0.13 B | 388.51% |
| 2016-09-30 | $28.05 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | -13.10% | 🇺🇸 USA |